Search Results for: OBE2109

Linzagolix (OBE2109)

Linzagolix (formerly OBE2109) is an experimental oral treatment being developed by ObsEva to ease symptoms of pain and heavy menstrual bleeding associated with endometriosis and uterine fibroids. The treatment was initially developed by Kissei Pharmaceutical. ... Read more

GnRH Receptor Antagonists

Endometriosis is a disease characterized by endometrial tissue, which normally lines the uterus, growing outside the uterus usually elsewhere in the abdominal cavity. These extra-uterine growths swell and shed ... Read more

Dysmenorrhea (Painful Periods)

Endometriosis is a disease where tissue resembling the endometrium (the tissue that lines the uterus) grows in lesions or patches outside the uterus. These lesions swell and shed with ... Read more

Hormonal Therapy

Endometriosis results when tissue resembling the endometrium that lines the uterus grows elsewhere, usually in the pelvic area. This tissue swells and sheds with the menstrual cycle, as the endometrium does. ... Read more

Experimental Treatments

Endometriosis is a condition in which the endometrium, or tissues lining the uterus, grow outside the uterus, usually in the abdomen. The implanted tissue swells and sheds during the ... Read more